Cara Therapeutics Inc call shares owned by Simplex Trading
Quarter-by-quarter ownership of Cara Therapeutics Inc call shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Cara Therapeutics Inc call
Tip: Access up to 7 years of quarterly data
All positions including Cara Therapeutics Inc call held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cara Therapeutics Inc call by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $0 | 200 | 0.00 |
| 2024-06-30 | $0 | 200 | 0.00 |
| 2024-03-31 | $0 | 700 | 0.00 |
| 2023-12-31 | $3.0k | 4.2k | 0.71 |
| 2023-09-30 | $7.0k | 4.2k | 1.67 |
| 2023-06-30 | $24k | 8.8k | 2.73 |
| 2023-03-31 | $33k | 6.9k | 4.78 |
| 2022-12-31 | $144k | 14k | 10.67 |
| 2022-09-30 | $136k | 15k | 9.32 |
| 2022-06-30 | $154k | 17k | 9.11 |
| 2022-03-31 | $501k | 41k | 12.13 |
| 2021-12-31 | $885k | 61k | 14.44 |
| 2021-09-30 | $885k | 61k | 14.44 |
| 2021-06-30 | $874k | 61k | 14.26 |
| 2021-03-31 | $1.6k | 741 | 2.17 |
| 2020-12-31 | $2.4k | 1.6k | 1.51 |
| 2020-09-30 | $403 | 317 | 1.27 |
| 2020-06-30 | $671 | 393 | 1.71 |
| 2020-03-31 | $254 | 193 | 1.32 |
| 2019-12-31 | $423 | 263 | 1.61 |
| 2019-09-30 | $219 | 120 | 1.83 |
| 2019-06-30 | $896 | 417 | 2.15 |
| 2019-03-31 | $445 | 227 | 1.96 |
| 2018-12-31 | $208 | 161 | 1.30 |
| 2018-09-30 | $643 | 269 | 2.39 |
| 2018-06-30 | $3.3k | 1.7k | 1.92 |
| 2018-03-31 | $26k | 166 | 156.63 |
| 2017-12-31 | $33k | 396 | 83.33 |
| 2017-09-30 | $51k | 451 | 113.08 |
| 2017-06-30 | $140k | 801 | 174.78 |
| 2017-03-31 | $181k | 294 | 615.65 |
| 2016-12-31 | $13k | 103 | 126.21 |
| 2016-09-30 | $127k | 841 | 151.01 |
| 2016-06-30 | $9.0k | 122 | 73.77 |
| 2015-12-31 | $3.0k | 15 | 200.00 |
| 2015-09-30 | $4.0k | 13 | 307.69 |
| 2015-06-30 | $2.0k | 16 | 125.00 |
| 2015-03-31 | $3.0k | 26 | 115.38 |
Top funds holding Cara Therapeutics Inc call
View all funds holding Cara Therapeutics Inc call